Quinethazone - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for quinethazone and what is the scope of patent protection?
Quinethazone
is the generic ingredient in two branded drugs marketed by Lederle and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for quinethazone
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Patent Applications: | 4,025 |
DailyMed Link: | quinethazone at DailyMed |
US Patents and Regulatory Information for quinethazone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | HYDROMOX | quinethazone | TABLET;ORAL | 013264-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | HYDROMOX R | quinethazone; reserpine | TABLET;ORAL | 013927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |